The use of pre-operative brain natriuretic peptides as a predictor of adverse outcomes after cardiac surgery: A systematic review and meta-analysis

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 3, 2012, Pages 525-534

  Litton, Edward ^a,b   Ho, Kwok M ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiac surgery; Mechanical circulatory assistance

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADVERSE OUTCOME; ANESTHESIA INDUCTION; COCHRANE LIBRARY; EMBASE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; INTRAAORTIC BALLOON PUMP; MEDLINE; META ANALYSIS; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VALIDITY; ARTICLE; BLOOD; PROGNOSIS;

BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREOPERATIVE PERIOD; PROGNOSIS; TREATMENT OUTCOME;

EID: 84861419729     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr007     Document Type: Review

References (33)

1. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
2. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 2009;120: 2177-87.
3. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74.
4. Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009;54:1599-606.
5. Nashef SA, Roques F, Hammill BG, Peterson ED, Michel P, Grover FL et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002;22:101-5.
6. Yap CH, Mohajeri M, Ihle BU, Wilson AC, Goyal S, Yii M. Validation of EuroSCORE model in an Australian patient population. ANZ J Surg 2005; 75:508-12.
7. Toumpoulis IK, Anagnostopoulos CE, Swistel DG, DeRose JJ Jr. Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur J Cardiothorac Surg Official J Eur Assoc Cardiothorac Surg 2005;27:128-33.
8. Ferguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute.Society of Thoracic Surgeons. Ann Thorac Surg 2002;73:480-9; discussion 9-90.
9. Landoni G,. Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010;24:51-7.
10. Field ML, Rengarajan A, Khan O, Spyt T, Richens D. Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting. Cochrane Database Systemic Reviews (Online) 2007:CD004472.
11. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6:31.
12. Akazawa T, Nishihara H, Iwata H, Warabi K, Ohshima M, Inada E. Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. J Anesth 2008;22:347-53.
13. Ata Y, Turk T, Ay D, Eris C, Demir M, Ari H et al. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Heart Surg Forum 2009;12:E211-6.
14. Attaran S, Sherwood R, Desai J, Langworthy R, Mhandu P, John L et al. Brain natriuretic peptide a predictive marker in cardiac surgery. Interact Cardiovasc Thorac Surg 2009;9:662-6.
15. Ballotta A, Ranucci M, Kunkl A, El Baghdady H, Bossone E, Castelvecchio S et al. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration. Am J Cardiol 2010; 105:640-4.
16. Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C et al. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study.Circulation 2007;115:2848-55.
17. Cerrahoglu M, Iskesen I, Tekin C, Onur E, Yildirim F, Sirin BH. N-terminal ProBNP levels can predict cardiac failure after cardiac surgery. Circ J 2007;71:79-83.
18. Cuthbertson BH, McKeown A, Croal BL, Mutch WJ, Hillis GS. Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 2005;33:437-42.
19. Cuthbertson BH, Croal BL, Rae D, Gibson PH, McNeilly JD, Jeffrey RR et al. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Br J Anaesth 2009;103:647-53.
20. Eliasdottir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand 2008;52:182-7.
21. Fellahi JL, Daccache G, Rubes D, Massetti M, Gerard JL, Hanouz JL. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European system for cardiac operative risk evaluation after cardiac surgery? J Cardiothorac Vasc Anesth 2010;25:256-62.
22. Fox AA, Muehlschlegel JD, Body SC, Shernan SK, Liu KY, Perry TE et al. Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology 2010;112: 842-51.
23. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004;43:1873-9.
24. Jogia PM, Kalkoff M, Sleigh JW, Bertinelli A, La Pine M, Richards AM et al. NT-pro BNP secretion and clinical endpoints in cardiac surgery intensive care patients. Anaesth Intens Care 2007;35:363-9.
25. Pedrazzini GB, Masson S, Latini R, Klersy C, Rossi MG, Pasotti E et al. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol 2008;102:749-54.
26. Pfister R, Wahlers T, Baer FM, Scherner M, Strauch J, Erdmann E. Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement. Clin Res Cardiol 2010;99:301-7.
27. Saribulbul O, Alat I, Coskun S, Apaydin AZ, Yagdi T, Kiliccioglu M et al. The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting. Tex Heart Inst J 2003;30:298-304.
28. Sezai A, Hata M, Niino T, Kasamaki Y, Nakai T, Hirayama A et al. Study of the factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention. J Thorac Cardiovasc Surg 2009;137:895-900.
29. Sodeck G, Domanovits H, Schillinger M, Janata K, Thalmann M, Ehrlich MP et al. Pre-operative N-terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J Am Coll Cardiol 2008;51:1092-7.
30. Tavakol M, Hassan KZ, Abdula RK, Briggs W, Oribabor CE, Tortolani AJ et al. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations. Ann Thorac Surg 2009;88:802-7.
31. Turk T, Ata Y, Ay D, Ozkan H, Vural H, Yavuz S et al. Plasma brain natriuretic Peptide after isolated on-pump coronary artery bypass grafting:prediction of postoperative adverse outcomes. Heart Surg Forum 2008;11:E84-9.
32. Wang Z, Liang D, Fu Q, Jia L, Men J, Wei M. Perioperative brain natriuretic peptide in off-pump coronary artery bypass. Acta Cardiol 2010;65: 297-301.
33. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004;110:124-7.